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Abstract
Introduction: Hypertension and chronic kidney disease 
(CKD) are common in our urban and rural communities 
but the majority of affected individuals are not aware of 
their condition. We conducted free medical examination 
and screening during one of the market days in Odo-Ogbe 
market, Ile-Ife, Nigeria to evaluate the magnitude of 
undiagnosed hypertension and proteinuria. 
Methods: Participants were taken through a brief medical 
history and had their socio-demographic data taken. 
Weight and height were measured and body mass index 
(BMI) calculated. Blood pressure (BP) was measured 
using a mercury sphygmomanometer and urinalysis was 
done with the aid of dipstick test. 
Results: A total of 286 participants aged 13-90 years 
(Mean 49.5 ± 15.7 years) were screened. Females 
constituted 90.2% of the study population. One-hundred 
and eight (37.7%) of participants had hypertension and 
only 20 (6.7%) were previously diagnosed. Sixty-nine 
participants (24.1%) had stage-1 hypertension while 39 
(13.6%) had stage-2 hypertension. Fifty-nine percent 
of participants had BMI above 25 kg/m2. Eighty five 
participants (29.7%) had proteinuria while only 13 
(4.5%) had glycosuria. A significantly higher percentage 
of participants with stage-1 and stage-2 hypertension had 
proteinuria compared with non hypertensives. There was 
a positive correlation between age and BMI (r = 0.171, 
P = 0.004), age and systolic BP (r = 0.378, P < 0.0001) as 
well as age and diastolic BP (r = 0.197, P = 0.001). 
Conclusion: A high percentage of the studied population 
(31%) had undiagnosed hypertension and proteinuria 
(29.7%). Community screening for these disabling non 
communicable diseases and lifestyle modifications 
should be encouraged. 
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Introduction
The prevalence of hypertension and chronic kidney 
disease (CKD) have increased exponentially in both the 
developing and developed countries in the last decade 
[1-3]. Hypertension is recognised to be a cause as well 
as a complication of CKD [4, 5]. While the prevalence 
of hypertension in rural and urban communities in 
Nigeria varies between 12-32.8% in different studies, the 
prevalence of CKD is still largely speculative as data is 
just emerging [1, 3, 6, 7]. The majority of patients with 
CKD undergo a progressive decline of renal function 
over years before requiring renal replacement therapy 
which is largely unafforadable in developing countries 
[1, 4, 5]. Hypertension and proteinuria are important 
risk factors for further deterioration in renal function 
irrespective of the cause of CKD [8, 9]. Furthermore, 
studies have established that interventions that decrease 
blood pressure (BP) level in patients with proteinuria and 
renal insufficiency consistently delay the progression of 
CKD [8-11]. As a result of the poor outlook of CKD in 
developing countries, which is particularly worse in sub-
Saharan Africa, the International Society of Nephrology 
(ISN), Commission for the Global Advancement of 
Nephrology (ISN-COMGAN) now reffered to as ISN 
Global Outreach Programs has made the fight against 
CKD one of its major priorities. These programs focus 
on promoting awareness, early detection and effective 
treatment as outlined by the Bellagio conference [12]. In 
a bid to create awareness of kidney disease, its causes 
and preventive strategies, we organised health education 
and screening in different populations in Nigeria as a 
way of commemorating World Kidney Day (WKD). 
This is a day set aside by the International Federation for 
Kidney Foundations (IFKF) and International Society of 
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Nephrology (ISN) on the second Thursday in the month of 
March every year. A major aspect of our WKD activities 
is screening for kidney disease or its markers and factors 
predisposing to it. On the 12th March 2009, we conducted 
health education, free medical examination and screening 
among a market population in Ile-Ife as part of the World 
Kidney Day celebration. Our objective was to define (if 
any) the magnitude of undiagnosed hypertension and 
proteinuria in this market population and assess factors 
that may influence both, including anthropometric indices. 
This study was presented at the Hypertension Teaching 
Seminar and International Federation for Hypertension 
in Africa conference held in Abuja in 2009.
Methods
All participants were recruited after an informed 
consent. They were taken through a brief medical 
history and had their sociodemographic data recorded. 
The BP was measured on the left arm using a mercury 
sphygmomanometer (Accoson, England) at heart level 
using appropriate cuff size. The subjects were allowed 
to relax for 3-5 minutes in a sitting position before 
assessment of BP. Hypertension was defined as a systolic 
blood pressure ≥140 mmHg or diastolic blood pressure 
≥ 90 mmHg and/or commitant use of antihypertensive 
medications by self report [7]. Blood Pressure was 
categorized according to the Seventh Joint National 
Committee Report on Detection, Evaluation and 
treatment of High Blood pressure [7].  The categories 
were as follows; normal: systolic BP (SBP) <120 and 
diastolic BP (DBP) of <80 mmHg, prehypertension: 
SBP 120-139 or DBP 80-89 mmHg, stage-1: SBP 140 
-159 or DBP  90-99 mmHg and stage-2: SBP ≥160 or 
DBP≥100mmHg.
Subjects were instructed on modality of collecting 
midstream urine specimen. Menstruating females were 
excluded from urinalysis. The participants thereafter 
provided urine samples which were tested using 
urinary medi-test Combi 2 test strips (Macherey-Nagel, 
Germany). Blood glucaose was not assessed as the 
majority of participants had taken breakfast before the 
screening.
Weights were taken using bathroom scale (Hana 
Weighing Scale, China) after removal of shoes and 
heavy clothings, while the heights were recorded using 
stadiometer. The body mass index (BMI) was calculated 
from the measured weight (in kilograms) and height 
(in meters) and was categorized as not obese (BMI 
< 25 kg/m2), overweight (BMI = 25-29.9 kg/m2) or obese 
(BMI ≥ 30 kg/m2) according to the 2000 WHO criteria 
[13].
Data was analysed using SPSS package version 16. 
Results are presented as frequencies and proportions or 
mean ± SD. Chi-square and Fishers exact tests were used 
for comparison of data where appropriate. Bivariate linear 
regression analysis was used to determine the association 
between anthropometric parameters and hypertension. P 
value <0.05 indicated statistical significance.
Results
A total of 286 participants were screened. Their age 
ranged between 13-90 years (mean ± SD; 49.5 ± 15.7). 
There was female preponderance with 278 of participants 
(90.2%) being females. Systolic and diastolic blood 
pressures ranged between 90-220 mmHg and 50-120 
mmHg respectively. One-hundred and eight participants 
(37.7%) had hypertension out of which only 20 (6.7%) 
were previously diagnosed. Sixty nine (24.1%) of 
participants had stage-1 hypertension while 39 (13.6%) 
had stage-2 (JNC VII). 
The BMI ranged between 15.6 and 46.6 kg/m2 (Mean ± 
SD; 26.76 ± 5.28 kg/m2). Twenty one (7.4%) subjects had 
BMI <20 kg/m2, 96 (33.4%) had BMI between 20-25 kg/
m2 and the remaining 169 (59.2%) of participants had 
BMI above 25 kg/m2 (35.6% of them had BMI between 
25-29.9 kg/m2 and 23.6% had BMI greater than 30 kg/
m2). 
Eighty-five participants (29.7%) had proteinuria 
while only 13 (4.5%) had glycosuria. A significantly 
Table 1:  Distribution of proteinuria and glycosuria according to blood pressure category
Normal BP Stage-1 HTN Stage-2 HTN P value
Presence of proteinuria
     Negative 140 (78.7%) 38 (55.1%) 23 (59%) 0.0001
     Positive 38 (21.3%) 31 (44.9%) 16 (41%)
Presence of glycosuria
     Negative 172 (96.6%) 63 (91.3%) 38 (97.4%) 0.01
     Positive 6     (3.4%) 6   (8.7%) 1   (2.6%)
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higher percentage of participants with stage-1 and 
stage-2 hypertension had proteinuria compared with 
non-hypertensive subjects (Table-1). Similarly a 
significantly higher percentage of participants with 
stage-1 hypertension had glycosuria compared with non-
hypertensive participants (P = 0.01) (Table-1). There was 
a significant positive correlation between age and BMI 
(r = 0.171, P = 0.004), age and systolic BP (r = 0.378, 
P < 0.0001) as well as age and diastolic BP (r = 0.197, 
P = 0.001) (Figures 1-3).
Discussion
Hypertension and CKD are assuming epidemic 
proportions globally and both contribute significantly to 
cardiovascular morbidity and mortality in developed and 
developing economies [1-11]. Prevalence of hypertension 
in Nigeria varies between 12 and 32.8% in available 
data sources and one third of hypertensive subjects are 
unaware of their hypertensive status [3, 6, 7]. About 38% 
of participants in this study had hypertension which was 
severe in 14%. Our findings are in agreement with the 
findings of Ulasi et al [7] who found a prevalence of 
hypertension of 32.8% in their population based survey. 
These figures are higher than earlier reports from this 
environment and this may probably be a consequence of 
the high prevalence of overweight and obese subjects in 
both study populations. The National non-communicable 
disease survey conducted about 18 years ago revealed a 
prevalence of 12% which is significantly lower than the 
prevalence found in this study [14]. Our figures and those 
of Oladapo et al [6] in western Nigeria and Ulasi et al [7] 
in eastern part of the country suggest that the prevalence 
of hypertension in our environment is increasing. 
Chronic kidney disease not only predisposes to ESRD but 
also imposes a huge cardiovascular disease burden which 
is one of the leading causes of death in CKD patients all 
over the world [5, 15, 16]. A number of factors have been 
shown to be associated with CKD, these include, ageing, 
hypertension, impaired glucose tolerance or diabetes 
mellitus, dyslipidemia, obesity and smoking [17-24]. 
An interventional approach that would prevent the 
development and progression of CKD at a community 
level would thus involve the control of all these factors 
simultaneously, the so called multi-hit hypothesis. 
The high prevalence of undiagnosed and untreated 
hypertension in this study is a clarion call for institution 
of efforts towards prevention of hypertension and its risk 
factors even in our rural and semi-urban populations. This 
would on the long term contribute to reduction in CKD 
burden and its associated cardiovascular risk [17, 18]. 
In addition, this study demonstrated that about a third of 
screened subjects had proteinuria which worsened with 
the severity of hypertension. Some earlier studies have 
documented that subjects with macroproteinuria are the 
groups at high risk of cardiovascular disease and CKD 
progression [25-32]. Identifying individuals in the early 
stages of CKD with proteinuria is of utmost importance, 
Figure 1: Correlation between age (years) and BMI (kg/m2) 
(r = 0.171, P=0.004)
Figure 2: Correlation between age (years) and systolic BP 
(mmHg) (r = 0.378, P=0.0001)
Figure 3: Correlation between age (years) and diastolic BP 
(mmHg) (r = 0.197, P=0.001)
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especially as there is strong evidence that the CVD risk 
associated with stages 1 and 2 is nearly equal to that of 
stage 3 CKD [25].
The finding that elevated BP, both SBP and DBP were 
associated with proteinuria was not unexpected as the 
relationship between hypertension and CKD has been 
well established [5, 29, 30]. In addition, hypertensive 
nephrosclerosis is one of the leading causes of ESRD 
in our environment [33]. The Multiple Risk Factor 
Interventional Trial (MRFIT) [5] clearly established 
the fact that hypertension leads to chronic kidney 
damage. In another analysis of MRFIT data after 10 
year follow-up, it was shown that for every 9 mmHg 
increase in DBP, there was an associated odd ratio of 
1.37 for the presence of dipstick-positive proteinuria 
[28]. Elevated intraglomerular pressure which results 
in glomerulosclerosis and eventual increased protein 
trafficking has been suggested as the mechanism 
responsible for proteinuria in hypertension [28, 29]. 
This study also established that age positively correlated 
with BMI and BP. The age dependent increase in BP 
may be partly due to age dependent vascular sclerosis, 
glomerulosclerosis and salt sensitivity [4, 5, 17, 30-32]. 
Previous data have supported the hypothesis that 
increasing age is associated with increasing susceptibility 
to the effects of dietary sodium on BP [30].The ability 
of the kidney to excrete a salt load decreases with age, 
therefore older people may respond to high salt load 
with a greater increase in BP [30, 31]. This was also 
corroborated by a Kenyan longitudinal study, in which 
subjects were followed up for 18 months and there 
was a significant increase in BP with advancing age; in 
addition, older subjects had a greater increase in BP than 
younger ones [32]. The relationship between BMI and 
BP might be potentially confounded by dietary salt intake 
and physical activity level, both of which are difficult to 
standardize and measure across different ethnic groups. 
However, the risk of hypertension has been reported to 
be higher among groups with overweight and obesity in 
previous studies [7, 8, 34, 35].
Conclusion
This study demonstrated the high prevalence of 
undiagnosed hypertension and proteinuria in this market 
population. Age significantly correlated with BMI and 
BP. Therefore, community screening for these potentially 
disabling non-communicable diseases as well as 
institution of lifestyle modification should be encouraged. 
Strict control of BP and proteinuria is consequently 
recommended as the bedrock for prevention of CKD and 
its progression.
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